Shkreli’s infamous 4,000% price hike gets him a lifetime pharma banvar abtest_1826072 = new ABTest(1826072, ‘click’);

DMCA / Correction Notice
- Advertisement -


- Advertisement -

A federal court on Friday banned convicted fraudster Martin Shkreli from working in the pharmaceutical industry again in any capacity and ordered him to pay $64.6 million in profits from his infamous scheme that sold the life-saving drug Daraprim. Raised the price by more than 4,000 percent. ,

advertisement

US District Judge Dennis Cote issued a life ban Shkreli engaged in anti-competitive practices in order to protect Daraprim’s monopoly profits after finding out.

According to a lawsuit filed by the Federal Trade Commission and seven states—New York, California, Illinois, North Carolina, Ohio, Pennsylvania, and Virginia—Shkreli, his former pharmaceutical company Vira (formerly Turing), and Vera’s former CEO, Kevin Muledi, Make. a “A web of competitive sanctions to stand out from the competition“In 2015 when they bought the rights to Daraprim.

- Advertisement -

Daraprim is an inexpensive, decades-old anti-parasitic drug used to treat toxoplasmosis, which often sickens people with weakened immune systems (such as AIDS patients) and can be fatal to newborns. Shkreli and Muledi reportedly set up a complex plan that kept the drug out of the hands of competitors, prohibited suppliers from selling critical pharmaceutical ingredients to competitors, and blocked the release of sales data that would give competitors an edge over the size of the market. will reveal

Meanwhile, Shkreli and Muledi suddenly raised the DaraPrime’s list price by more than 4,000 percent, from $17.50 to $750 per tablet.

a better tomorrow

In the quota ruling on Friday, she concluded that Shkreli “was the mastermind of [Vyera’s] Illegal conduct and the person primarily responsible for it for years.” His lifetime ban and order to pay $64.6 million “serves the interests of justice,” she wrote.

In a press release On Friday, New York Attorney General Letitia James celebrated the decision with some references to the Wu Tang clan.

“‘Envy, greed, lust, and hatred,’ not only ‘isolate’, but they apparently inspired Mr. Shkreli and his partner to illegally raise the price of a life-saving drug because Americans’ lives are in the balance. hung up,” Attorney General James said, referencing Wu Tang Clan songs a better tomorrow,

“But Americans can rest easy because Martin Shkreli is no longer a pharma brother… the rich and powerful don’t get to play by their own set of rules, so it seems that cash doesn’t rule everything around Mr. Shkreli. It is,” Attorney General James continued.

Friday’s ruling follows a settlement announced last month in which Vera and her parent company, Phoenix, agreed to pay up to $40 million to victims of the Daraprime scheme. The settlement required companies to make Daraprime available to competitors at a price and barred them from entering into any similar schemes for 10 years. Muledi was banned from the pharmaceutical industry for seven years.

Shkreli, meanwhile, is currently serving a seven-year prison sentence from a 2017 securities fraud conviction involving two hedge funds prior to the Daraprime scheme. Following his fraud conviction, he was ordered to forfeit $7.36 million in assets, including the sole copy of the Wu-Tang album. Once Upon a Time in Shaolin, which he bought at auction in 2015 from Wu-Tang member RZA for $2 million.

- Advertisement -

Stay on top - Get the daily news in your inbox

Recent Articles

Related Stories